Medical Devices Series C Investors & VC Firms

439 firms in this list, with a median first check of $1M. 92 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Cutlass Capital, L.L.C. 1 person	Boston	US	Seed–Late Stage	$3M – $7M	+ Add to CRM
Kenson Ventures, LLC 1 person	Menlo Park	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
Yuanta Investment	Seoul	KR	Seed–Late Stage	$1M – $15M	+ Add to CRM
Omron Ventures 2 people	Kyoto	JP	Seed–Growth	—	+ Add to CRM
Ameba Capital 3 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
ePlanet Capital 3 people	San Jose	US	Seed–Late Stage	—	+ Add to CRM
CBC Group 2 people	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
Wellcome Trust	London	GB	Seed–Late Stage	—	+ Add to CRM
DEEPCORE Inc.	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
BSK Investment 2 people	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
Wild Basin Investments 2 people	Texas	US	Seed–Growth	—	+ Add to CRM
INCJ, Ltd. 1 person	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
Brandon Capital Partners	—	AU	Seed–Growth	—	+ Add to CRM
Hanne Capital 2 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Ippon 1 person	Geneva	CH	Series A–Growth	—	+ Add to CRM
Shanghai STVC Group 1 person	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Woodford Investment Management	Oxford	GB	Series A–Growth	—	+ Add to CRM
Augere Venture 1 person	Kraków	PL	Seed–Late Stage	—	+ Add to CRM
Ilshin Investment Co. Ltd. 1 person	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
3H Health Investment	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
Roadmap Capital Inc.	Toronto	CA	Seed–Late Stage	—	+ Add to CRM
Capital Medica Ventures	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
Providence Investment Company Limited	Germany	US	Seed–Growth	—	+ Add to CRM
Santen Pharmaceutical	Osaka	JP	Series A–Series C	—	+ Add to CRM